Fargesone B

Fargesone B
Product Name Fargesone B
CAS No.: 116424-70-5
Catalog No.: CFN96260
Molecular Formula: C21H24O6
Molecular Weight: 372.4 g/mol
Purity: >=98%
Type of Compound: Lignans
Physical Desc.: Oil
Targets: Calcium Channel | cAMP
Source: The flowers of Magnolia fargesii
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price:
Fargesone B inhibits the vascular smooth muscle contraction by suppressing the voltage- and receptor-activated calcium influxes in a nonselective manner.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Int Immunopharmacol.2023, 7:127:111322.
  • Postharvest Biol Tec2019, 149:18-26
  • Plants (Basel).2023, 12(1):163.
  • Toxicol In Vitro.2024, 99:105876.
  • Neuropharmacology2019, 151437
  • Chemistry of Plant Raw Materials2019, 4:135-147
  • J Drug Target.2016, 24:1-28
  • Thorac Cancer.2023, 14(21):2007-2017.
  • J. Korean Wood Sci. Technol.2022, 50(5):338-352.
  • Regul Toxicol Pharmacol.2023, 142:105433.
  • 3a-Epiburchellin

    Catalog No: CFN96709
    CAS No: 155551-61-4
    Price: Inquiry(manager@chemfaces.com)
    2-Epi-3a-epiburchellin

    Catalog No: CFN96707
    CAS No: 57457-99-5
    Price: Inquiry(manager@chemfaces.com)
    Isofutoquinol A

    Catalog No: CFN91836
    CAS No: 62499-70-1
    Price: $388/5mg
    Hancinone C

    Catalog No: CFN97876
    CAS No: 111843-10-8
    Price: Inquiry(manager@chemfaces.com)
    Wallichinine

    Catalog No: CFN96307
    CAS No: 125292-97-9
    Price: Inquiry(manager@chemfaces.com)
    Futoquinol

    Catalog No: CFN96249
    CAS No: 28178-92-9
    Price: $388/5mg
    Isodihydrofutoquinol B

    Catalog No: CFN96400
    CAS No: 62499-71-2
    Price: Inquiry(manager@chemfaces.com)
    Isodihydrofutoquinol A

    Catalog No: CFN96401
    CAS No: 62560-95-6
    Price: Inquiry(manager@chemfaces.com)
    Fargesone A

    Catalog No: CFN96245
    CAS No: 116424-69-2
    Price: Inquiry(manager@chemfaces.com)
    Fargesone B

    Catalog No: CFN96260
    CAS No: 116424-70-5
    Price: Inquiry(manager@chemfaces.com)
    Asia Pacif. J. Pharmacol.,1990,v.5:213-8.
    Vasorelaxation of Rat Aorta by Fargesone B Isolated from the Flower buds of Magnolia Fargesii[Reference: WebLink]
    The effect of Fargesone B, isolated from Magnolia fargesii, on the contraction of rat aorta was studied.
    METHODS AND RESULTS:
    Fargesone B suppressed the contraction of aortic rings caused by cumulative concentrations of calcium (0.03-3 mM) in high potassium (60 mM) medium, with an IC50 of 12 .mu.g ml-1. It also relaxed the norepinephrine (NE, 3 .mu.M)-induced contraction, and its pretreatment inhibited both the phasic and tonic contractions elicited by NE, with an IC50 of about 100 and 30 .mu.g ml-1, respectively. This inhibition was also observed in the absence of calcium in the medium. It did not inhibit caffeine-induced phasic contraction. In quin-2-loaded cultured vascular smooth muscle cells, Fargesone B suppressed the rise of intracellular calcium caused by NE but not that by caffeine. 45Ca++ uptake by NE was also concentration-dependently inhibited by Fargesone B. Fargesone B did not change the levels of PGI2, cGMP or cAMP of rat aorta.
    CONCLUSIONS:
    It is concluded that Fargesone B inhibits the vascular smooth muscle contraction by suppressing the voltage- and receptor-activated calcium influxes in a nonselective
    5-Hydroxy-7-(4'-hydroxy-3'-methoxyphenyl)-1-phenyl-3-heptanone (DHPA)

    Catalog No: CFN95135
    CAS No: 79559-61-8
    Price: $268/20mg
    Patulitrin

    Catalog No: CFN95153
    CAS No: 19833-25-1
    Price: $318/10mg
    1,7-Diphenyl-5-hydroxy-4,6-hepten-3-one

    Catalog No: CFN95171
    CAS No: 87095-77-0
    Price: $318/10mg
    5-Hydroxy-7,8-dimethoxy (2R)-flavanone-5-O-beta-D-glucopyranoside

    Catalog No: CFN95209
    CAS No: 942626-74-6
    Price: $318/10mg
    Ginsenoside Rd2 (Quinquenoside L10)

    Catalog No: CFN95231
    CAS No: 83480-64-2
    Price: $318/10mg
    Quasipanaxatriol

    Catalog No: CFN95248
    CAS No: 171903-78-9
    Price: $413/5mg
    Perlolyrine

    Catalog No: CFN95291
    CAS No: 29700-20-7
    Price: $413/5mg
    New compound 12 (Rhoifolin analog)

    Catalog No: CFN95371
    CAS No: N/A
    Price: $318/5mg
    Oxytroflavoside E

    Catalog No: CFN95464
    CAS No: 1391144-84-5
    Price: $318/5mg
    Oxytroflavoside F

    Catalog No: CFN95489
    CAS No: 1391144-85-6
    Price: $318/5mg